Oxaliplatin Injection
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Open FDA's page for this record- Discontinued date
- 06/29/2026
- Update type
- New
- Initial posting date
- 06/29/2026
- Package NDC
- 25021-233-20
- Generic name
- Oxaliplatin Injection
- Contact info
- Sagent Pharmaceuticals: 866-625-1618
- Related info
- Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug
- Update date
- 06/29/2026
- Dosage form
- Injection
- Presentation
- Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20)
- Company name
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Status
- To Be Discontinued
- Therapeutic category
- Oncology
- Harmonized identifiers (openFDA)
- Application number
- ANDA203869
- Brand name
- OXALIPLATIN
- Generic name
- OXALIPLATIN
- Manufacturer name
- Sagent Pharmaceuticals
- Product NDC
- 25021-233
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- OXALIPLATIN
- RxCUI
- 1736776, 1736781
- SPL ID
- c159050a-e588-4091-b9ee-ea502e1b9529
- SPL set ID
- 29a5d098-bfa7-4a65-bb4f-5daa1fef1c2f
- Package NDC
- 25021-233-10, 25021-233-20
- Nui
- N0000175413, N0000175073
- Pharm class epc
- Platinum-based Drug [EPC]
- UNII
- 04ZR38536J
